Exchange: NASDAQ·Updated 07:30 PM EDT
SNDX logo

SNDX Syndax Pharmaceuticals Inc

$20.10
$0.81
(4.20%)
Today
Closed $20.10
$0.00
(0.00%)
After Hours
Reported EarningsAug 4
Mkt Cap$1.72B
Vol1.41M

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.
45

Neutral Sentiment

How do you feel about SNDX?

Advertisement|Remove ads.